Orlando, FLORIDA1 Active Studies

Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Orlando, FLORIDA

Find 1 actively recruiting paroxysmal nocturnal hemoglobinuria clinical trials in Orlando, FLORIDA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
111
Enrolling

Recruiting Paroxysmal Nocturnal Hemoglobinuria Studies in Orlando

About Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Orlando

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disease where the immune system destroys red blood cells, causing dark-colored urine, fatigue, and blood clots. It is caused by a genetic mutation in blood stem cells. Treatment includes complement inhibitors like eculizumab.

There are currently 1 paroxysmal nocturnal hemoglobinuria clinical trials recruiting participants in Orlando, FLORIDA. These studies are seeking a combined 111 participants. Research is being sponsored by Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Orlando — FAQ

Are there paroxysmal nocturnal hemoglobinuria clinical trials in Orlando?

Yes, there are 1 paroxysmal nocturnal hemoglobinuria clinical trials currently recruiting in Orlando, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orlando?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orlando research site will contact you about next steps.

Are clinical trials in Orlando free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orlando studies also compensate for your time and travel.

What paroxysmal nocturnal hemoglobinuria treatments are being tested?

The 1 active trials in Orlando are testing new therapies including novel drugs, biologics, and treatment approaches for paroxysmal nocturnal hemoglobinuria.

Data updated March 2, 2026 from ClinicalTrials.gov